Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer

Since the CD44 variant 6(v6) molecule has been noted as a marker for tumor metastasis and prognosis in several tumors, we examined whether or not v6 is a useful marker for evaluating the prognosis of pancreatic cancer patients. In addition, we attempted to assess the clinicopathological implications...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotoda, Takuji, Matsumura, Yasuhiro, Kondo, Hitoshi, Saitoh, Daizo, Shimada, Yasuhiro, Kosuge, Tomoo, Kanai, Yae, Kakizoe, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1998
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921704/
https://www.ncbi.nlm.nih.gov/pubmed/9849582
http://dx.doi.org/10.1111/j.1349-7006.1998.tb00493.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921704/
https://www.ncbi.nlm.nih.gov/pubmed/9849582
http://dx.doi.org/10.1111/j.1349-7006.1998.tb00493.x

Ejemplares similares